Skip to content

A Strategic Approach to

Public & Investor Relations

At HLTH Communications, we believe that clear, strategic communication is vital for building trust and fostering strong relationships. Our expert team crafts tailored public and investor relations strategies that resonate with your audience, ensuring your brand’s message is impactful and engaging. Whether you’re in biotech, neuroscience, mental health, psychedelics, or longevity, we help you navigate complex landscapes and achieve your goals through effective and thoughtful communication.

Amplify your story, ignite your success

At HLTH Communications, we specialize in transforming your unique story into powerful narratives that resonate and inspire. Our strategic approach leverages media relations, thought leadership, and innovative content strategies to amplify your brand’s presence and impact. By aligning your message with your audience’s values and interests, we help you ignite success, drive engagement, and achieve measurable business outcomes. Let us help you turn your vision into a compelling story that captivates and delivers results.

Natalie & Kristina

Our Services

Designed to meet the diverse needs of our clients

Thought Leadership

Developing and promoting expert insights positions you as a leader in your field, leveraging executive commentary, bylined articles, and speaking opportunities.

Investor Relations

Build and maintain strong investor relationships through transparent communication strategies that highlight financial performance and strategic vision.

Content Strategy & Design

Compelling content creation includes brand strategy, creative writing, immersive digital experiences, and visual storytelling that resonate with your audience.

Media Relations

Achieve targeted media coverage by aligning your messaging with trends and establishing credibility through strategic campaigns.

Social Media

Engage investor communities with data-driven social media strategies that amplify your message and enhance your online presence.

Events

Ensure high engagement and seamless delivery with flawlessly planned and executed events, from large-scale conferences to intimate exhibitions.

Areas of Focus

We've helped leading brands across industries achieve measurable growth and market leadership

Biotech

We provide strategic communications for biotech companies, ensuring their groundbreaking innovations receive the attention they deserve.

Neuropsychiatry

Our expertise in neuropsychiatric communications helps companies in this field effectively convey complex medical information.

Neuroscience

Our firm supports neuroscience companies by creating compelling narratives that explain their research and breakthroughs.

Mental Health

We specialize in promoting mental health initiatives and organizations, using strategic communications to raise awareness and reduce stigma.

Psychedelics

We help psychedelic research and therapy companies communicate their innovative approaches and scientific findings.

Longevity

Our communications expertise in the longevity sector focuses on promoting advancements in life extension and healthy aging.

The Results

The numbers speak for themselves

$6.7M

USD Raised in Q1 2024

3x

Dominance in industry conversations within 6 months

65%

Average client year-over-year growth

Download Our e-Book

Discover the Secrets to Successful Communication

Unveil the key to transforming public and investor relations in the healthcare and biotech industries. This eBook is your guide to mastering crisis communication, engaging the media, and aligning financial narratives with public storytelling. Featuring actionable checklists and real-world case studies, it’s a must-read for professionals looking to elevate their communication strategies.

Client Case Studies

Learn How We Did It

With Wonderland Conference, our mission was to amplify the event’s reach and impact, capturing the attention of diverse audiences and stakeholders through a targeted PR campaign and media partnerships.
MindBio Therapeutics partnered with us to promote their groundbreaking clinical trials in psychedelic microdosing, aiming to transform mental health treatment.
Enveric Biosciences focuses on developing cutting-edge neuroplastogenic small-molecule therapeutics to treat neuropsychiatric disorders. By leveraging their proprietary discovery platform, The Psybrary™, Enveric aims to transform mental health treatment.

Our Clients Have Been Featured In

Founders Led

Meet Our Team

Kristina Spionjak

🇬🇧 London, UK

Kristina Spionjak is a seasoned public relations professional with over 10 years of experience. She connects entrepreneurs with their ideal audiences across various industries through media relations and events. Kristina excels at managing PR campaigns and high-profile events, ensuring clients reach the right stakeholders.

Natalie Dolphin

🇨🇦 Toronto, Canada

Natalie Dolphin has over 15 years of experience in marketing, business development, and capital markets. She has a proven track record in raising capital, having secured $6.7M USD for clients in Q1 2024 alone, and excels in driving business growth and securing investment opportunites.

Play Video

Mentions in the Press

Celebrating Our Clients' success

Enveric Biosciences Inks Two Licensing Agreements With Restoration Biologics To Treat Joint Disease

On Tuesday, Enveric Biosciences’ wholly-owned subsidiary, Akos Biosciences, Inc., entered into two licensing agreements with Restoration Biologics LLC, a biotechnology company focused on treating joint disease. The companies have executed two licenses for Akos’ cannabinoid-COX-2 conjugate compounds for pharmaceutical and potential non-pharmaceutical applications.

Read Now

Zepbound vs. Wegovy: Which Is Better for Weight Loss? Experts Break Down New Study Results

With so many weight loss medications on the market, it’s easy to feel overwhelmed by the options. From brand-name heavy hitters to compounded varieties, each promises to help shed pounds. But a recent head-to-head trial comparing Zepbound vs. Wegovy provided new insights into their effectiveness, making the choice slightly clearer. The findings? Zepbound led to […]

Read Now

2025 predictions: Which trends are set to shape the biotech industry this year?

It is difficult these days to talk about biotech without mentioning the revolutionary role that AI is playing – and will continue to play – in the industry. When making these same predictions last year, we said that AI was likely to be a key biotech trend in 2024. This was most certainly the case, […]

Read Now

I tried the cognitive shuffling sleep technique, and now I fall asleep in three minutes

For most of my life, I slept soundly the moment my head hit the pillow. Ever since I moved countries over a year ago, things changed. Sleep didn’t come as easily. Despite feeling adequately tired by bedtime, I’d lie awake, my mind racing with worries about work or conjuring up hypothetical scenarios about my loved […]

Read Now

Enveric Biosciences Advances Non-Hallucinogenic DMT Analog Drug With Promising Preclinical Results

Psychedelics biotech company Enveric Biosciences completed preclinical pharmacokinetic (PK) studies for its leading drug candidate EB-003 aimed at treating depression and anxiety without causing hallucinations. EB-003 is a neuroplastic and non-hallucinogenic N, N-Dimethyltryptamine (DMT) analog drug candidate., such as ataxia or hyperthermia.

Read Now

New study reveals the popular diet proven to ‘decrease’ the risk of cognitive decline – but only in women

Wondering how you can boost your brain health? A new study has found that sticking to one popular diet can help maintain a healthy brain and “decrease” the risk of cognitive decline over the years to come.

Read Now

23/01/2025

|

23 min

The Business of Hlth Podcast

Listen to the latest episode of our podcast

The Business of HLTH podcast, a HLTH Communications Production, provides an in-depth look at the evolving health sector. We interview investors and innovators, exploring the latest in health tech, longevity and biotech investments, uncovering where capital is moving. Join us for insights into the future of health.

How we will work with you

Our Process

1 Research

Our initial focus will be on examining your past actions to determine what has been effective and what hasn’t. We’ll also delve into understanding your target audience, collecting essential messages and materials, and clarifying your objectives. Additionally, we’ll analyze your competitors’ marketing strategies to identify successful approaches.

2 Implementation

Following the research phase, we’ll develop and align a Media Relations program with your broader marketing strategy. This will involve setting up your press office and brainstorming pitch ideas.

3 Pitch Pitch Pitch

Through meticulous planning, organization, and interaction with journalists, we aim to secure high-quality coverage for you. This will contribute significantly to building a positive and robust media presence, which will be highly valued by your customers and search engines like Google.

4 Evaluation

You’ll have real-time access to information about our pitch efforts, ongoing conversations with targeted journalists, and all metrics related to secured coverage.

Testimonials

Hear from Happy Customers

What I love most about working with HLTH Communications is how they confidently present their client’s expertise and convey the value it will bring to our readership. And they’re spot on. In addition to being dedicated client advocates, the team knows how to work well with journalists by being prompt, thorough, and cordial through every interaction — pitch to publication.
Abby Proch
Executive Director, Clinical Leader
HLTH Communications launched Equulus Therapeutics out of “Stealth Mode” and we went from being unknown to being a widely recognized neuroscience startup biotech virtually overnight. Their capabilities and contacts in the PR space provided us high visibility to the right companies at the right time to allow us to achieve the next critical steps in our company’s journey.
Bob Discordia
CEO, Equulus Therapeutics
HLTH is a dedicated, conscientious public relations firm that goes above and beyond to help journalists. Working with them is simple and I like their no nonsense, can-do attitude. I look forward to working with them again.
Mattha Louis Busby
Journalist
Working with Natalie and Kristina at HLTH is like working with your best friends who understand you, always be there for you and advocate for you with real passion! They are also trusted advisors that you can rely on for expert opinion on branding and PR issues. HLTH's professionalism, industry reach and hardwork is an integral part of PurMinds' growth and success!
Janet Qi, CPA, MBA
CEO, PurMinds Neuropharma
It has been a real pleasure working with HLTH Communications over the last few months. They make my life much easier as a journalist when I am looking to talk to relevant experts in the life sciences industry, reaching out to me with source suggestions perfectly suited to each individual topic I am writing about. Their professionalism and media relation skills are second to none and I can always count on them to provide a swift response and collect detailed answers from suggested sources in plenty of time before my proposed deadlines.
Willow Shah-Neville
Reporter Labiotech.eu

Take Your First Steps

Are you ready to elevate your brand?

Explore how we can help you achieve your goals and drive tangible business results.